Urologists and prostate cancer advocates say our prostate-specific antigen testing guidelines are out-of-date, and don’t account for advances that have reduced harms. The NHMRC and RACGP Red Book guidelines are undergoing review, and may ultimately promote more widespread use of PSA testing. But globally, epidemiologists remain concerned about overdiagnosis and overtreatment…
Expert/s: Lynnette Hoffman